Corporate Beneficence and COVID-19

被引:1
|
作者
Ostas, Daniel T. [1 ]
de los Reyes, Gaston [2 ]
机构
[1] Univ Oklahoma, Michael F Price Coll Business, Norman, OK 73072 USA
[2] George Washington Univ, Sch Business, Washington, DC USA
关键词
Beneficence; Adam Smith; social contract theory; corporate responsibility; RESPONSIBILITY; BUSINESS; INSIGHTS; LEGAL;
D O I
10.1177/0971685820973186
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
This article explores the motives underlying corporate responses to the COVID-19 pandemic. The analysis begins with Thomas Dunfee's Statement of Minimum Moral Obligation (SMMO), which specifies, more precisely than any other contribution to the business ethics canon, the level of corporate beneficence required during a pandemic. The analysis then turns to Milton Friedman's neoliberal understanding of human nature, critically contrasting it with the notion of stoic virtue that informs the works of Adam Smith. Friedman contends that beneficence should play no role in corporate settings. Smith, by contrast, emphasizes the need for prudence, beneficence and self-command in all human endeavours. The article then uses these competing frameworks to reflect on a published survey of 145 corporate responses to COVID-19. In many of these responses, the benefit to a non-financial stakeholder is clear, while the financial consequence to the firm remains nebulous. This supports the contention that during a pandemic, beneficence provides a more complete explanation of many corporate actions than the profit motive alone. The article contests Friedman's Chicago School profit imperative and goes beyond Dunfee's SMMO by endorsing the more full-throated embrace of beneficence and stoic virtue found in the works of Smith.
引用
收藏
页码:15 / 26
页数:12
相关论文
共 50 条
  • [41] The effect of the COVID-19 pandemic on corporate trade credit financing
    Xie, Wenlan
    Tian, Haowen
    ECONOMICS LETTERS, 2023, 232
  • [42] HANDLING CORPORATE CRIMES IN INDONESIA AMIDST THE COVID-19 PANDEMIC
    Simangunsong, Marthin
    Syahrin, Alvi
    Kamello, Tan
    Sirait, Ningrum Natasya
    RUSSIAN LAW JOURNAL, 2023, 11 (01) : 30 - 36
  • [43] UK Biotech Corporate Finance Trends Post COVID-19
    Malhotra, Sunjay
    Stanier, Julian
    BIOTECHNOLOGY LAW REPORT, 2020, 39 (05) : 381 - 384
  • [44] Sustainable corporate governance and gender diversity on corporate boards: evidence from COVID-19
    Naeem, Muhammad Abubakr
    Karim, Sitara
    Nor, Safwan Mohd
    Ismail, Rusmawati
    ECONOMIC RESEARCH-EKONOMSKA ISTRAZIVANJA, 2022, 35 (01): : 5824 - 5842
  • [45] BUSINESS ETHICS AND CORPORATE SOCIAL RESPONSIBILITY IN TIMES OF COVID-19
    Tanna, Ashish
    Conti, Diego de Melo
    da Silva, Luciano Ferreira
    RISUS-JOURNAL ON INNOVATION AND SUSTAINABILITY, 2021, 12 (03): : 4 - 11
  • [46] COVID-19 and the cost of bond debt: The role of corporate diversification
    Almaghrabi, Khadija S.
    FINANCE RESEARCH LETTERS, 2022, 46
  • [47] Private Security and Corporate Security during COVID-19 in Slovenia
    Sotlar, Andrej
    Dvojmo, Miha
    REVIJA ZA KRIMINALISTIKO IN KRIMINOLOGIJO, 2021, 72 (01): : 79 - 90
  • [48] Corporate philanthropic response to the COVID-19 pandemic in China: a dilemma?
    Zou, Hailiang
    Liang, Zedong
    Qi, Guoyou
    Ma, Hanyang
    SOCIAL RESPONSIBILITY JOURNAL, 2023, 19 (06) : 1085 - 1106
  • [49] The value of corporate cash holdings during the Covid-19 pandemic
    Veerhoek, Jan Pieter
    APPLIED ECONOMICS, 2024, 56 (53) : 6821 - 6838
  • [50] Corporate philanthropy and corporate social irresponsibility during the COVID-19 pandemic: evidence from China
    Ahmad, Muhammad Ishfaq
    Cepel, Martin
    Battisti, Enrico
    Rehman, Ramiz Ur
    INTERNATIONAL JOURNAL OF EMERGING MARKETS, 2025, 20 (03) : 1000 - 1018